Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
134,530,456
-
Share change
-
+4,167,253
-
Total reported value
-
$5,519,019,946
-
Put/Call ratio
-
69%
-
Price per share
-
$41.03
-
Number of holders
-
295
-
Value change
-
+$183,377,765
-
Number of buys
-
128
-
Number of sells
-
150
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q2 2023
As of 30 Jun 2023 IONIS PHARMACEUTICALS INC - Common Stock (IONS) had 295 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 134,530,456 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., Bellevue Group AG, BlackRock Inc., Clearbridge Investments, LLC, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, Tweedy, Browne Co LLC, and PICTET ASSET MANAGEMENT SA.
This table shows 299 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.